Patent Licensing Opportunities

1. Diagnostic
S. No. Patent No. Title Filing Date Indication Summary
1 IN405747B In-vitro detection of herpes simplex virus 2014-11-05 Herpes simplex virus A testing kit for the in-vitro detection of Human Herpes Simplex Virus 1 (HSV-1) and Virus 2 (HSV-2) using multiplex RT-PCR methodology, comprising specific primers and probes designed for high sensitivity and specificity.
2 IN435183B A diagnostic device and method for differentiating Asthma-COPD overlap syndrome (ACO) from asthma and COPD 2020-08-19 Asthma, COPD A method for preparing an electrochemical immunosensor on a gold electrode for the early and accurate diagnosis of Asthma-COPD Overlap.
3 IN471729B A paper-disc based method for determining the drug susceptibility of mycobacterium tuberculosis 2020-04-29 Tuberculosis Syndrome (ACO) utilizing a self-assembled monolayer (SAM) and Interleukin-4 (IL-4) as a biomarker. A method for utilizing paper discs to determine the drug susceptibility of Mycobacterium tuberculosis, particularly against rifampicin and isoniazid, within a rapid timeframe.
4 IN448323B In-vitro detection of human parvovirus 4 2014-11-05 Human parvovirus 4 The invention relates to primers and probes designed for the in-vitro detection of human parvovirus 4, utilizing specific nucleotide sequences that enable high sensitivity across all genotypes.
5 IN438631B Sulfadoxine and pyrimethamine (sp) resistance in plasmodium falciparum, through loop mediated isothermal amplification (lamp) 2018-10-25 Vector Borne Diseases This invention relates to a method for detecting resistance to Pyrimethamine and Sulfadoxine in the malaria-causing parasite Plasmodium falciparum by utilizing specific primers designed for loop-mediated isothermal amplification (LAMP).
6 IN429781B Assay to investigate multiple genes as host genetic risk markers for enterovirus A71 infection severity 2018-06-21 Enterovirus A71 infections This invention relates to multiplex primers designed for a non-diagnostic assay aimed at investigating multiple single nucleotide polymorphisms (SNPs) as host genetic risk markers for susceptibility to Enterovirus A71.
7 IN380417B Rapid detection of drug resistant plasmodium falciparum through a novel approach using loop mediated isothermal amplification 2017-03-17 Vector Borne Diseases A novel method for detecting chloroquine resistance in Plasmodium falciparum through loop-mediated isothermal amplification (LAMP) utilizing specifically designed primers targeting the PfCRT gene.
8 IN327506B Loop mediated isothermal amplification (lamp) assay for a reliable and rapid diagnosis of leishmania infection 2014-02-06 Vector Borne Diseases This invention relates to a set of primers specifically designed for Loop Mediated Isothermal Amplification (LAMP) assay aimed at detecting multiple species of Leishmania, including L. donovani and L. tropica, with enhanced sensitivity and efficiency.
9 IN426216B A novel molecular diagnostic technique for detecting the different species of plasmodium 2015-01-30 Vector Borne Diseases A novel method for identifying species of Plasmodium, including P. falciparum, P. vivax, P. malariae, and P. ovale, through genomic DNA isolation, mitochondrial gene amplification, restriction enzyme digestion, and analysis.
10 IN257150B A primer set and a process for the detection of l3 larval stage of wuchereria bancrofti 2006-12-26 Vector Borne Diseases A method for detecting the L3 larval stage of the filarial parasite Wuchereria bancrofti in mosquito vectors, specifically Culex quinquefasciatus, utilizing a set of specific primers.
2. Vaccines
S. No. Patent No. Title Filing Date Indication Summary
1 IN283894B A novel salmonella typhi protein as subunit vaccine 2010-03-05 GI Infection A recombinant protein vaccine targeting Salmonella Typhi, comprising the polypeptide t2544 and a pharmaceutically acceptable carrier, optionally emulsified with adjuvants.
2 IN502420B A multi-serotype outer membrane vesicles (momv) of shigellae as a novel candidate vaccine 2013-05-31 Shigellosis A novel vaccine formulation comprising outer membrane vesicles (oMVs) from six serotypes of Shigella, designed to provide broad-spectrum protection against shigellosis.
3 IN570035B A bivalent outer membrane vesicle (bomvs) based vaccine against typhoidal salmonellae 2017-03-31 Enteric Fever A vaccine consortium comprising isolated Outer Membrane Vesicles (OMVs) from two distinct strains of typhoidal Salmonella species, specifically Salmonella Typhi C-6953 and Salmonella Paratyphi A C-6915, designed for the treatment of enteric fever.
3. Devices
S. No. Patent No. Title Filing Date Indication Summary
1 IN514056B A non-invasive system for detection of analytes and applications thereof 2020-02-25 Heavy metal Poisoning A system designed for the rapid and non-invasive detection of lead in various biological and environmental samples, utilizing a colorimetric method for qualitative assessment.
2 IN484477B A squa-tool apparatus 2019-10-24 Pregnancy A squa-tool apparatus designed to provide adjustable support for pregnant women in a squatting position during childbirth, featuring an upper frame with a seat, armrests, backrest, and a lower frame with telescopic legs for height adjustment.
3 IN554978B High precision surgical robotic platform for cooperative and teleoperated minimal invasive surgeries 2019-01-11 Surgical Platforms A robotic surgical system designed for performing minimally invasive surgeries (MIS), specifically targeting high precision and tremor-free applications such as retinal surgeries.
4 IN462107B Neuro-drill-stencil-trainer 2014-10-08 Neurosurgery A device designed to assist in the training of neurosurgical drilling procedures by providing stencils for accurate demarcation on both flat and curved bone surfaces.
5 IN501025B Neuro-endoscope box trainer 2014-10-08 Neurosurgery An innovative electro-mechanical box trainer designed specifically for neurosurgery training, featuring a motorized peg plate, rubberized working port, and integrated auxiliary camera for skill evaluation.
6 IN543446B Wireless mouse and keyboard device for handicapped 2018-08-31 Disability A device designed to assist handicapped or disabled individuals in using computer systems through a spectacle-mounted interface.
4. Therapeutics
S. No. Patent No. Title Filing Date Indication Summary
1 IN493164B Tricompartmental microcarriers for management of Parkinson's disease 2021-09-04 Parkinson's Disease A tricompartmental microcarrier system designed for the treatment of Parkinson's disease, featuring distinct polymer matrices for controlled release of Levodopa, Carbidopa, and Entacapone.
2 IN371495B RNAi agent for inhibition of chikungunya virus 2013-07-02 Chikungunya virus This invention relates to RNA interference (RNAi) agents specifically designed to inhibit the Chikungunya virus (CHKV) by targeting its E2 and nsP1 genes through the use of small interfering RNA (siRNA) sequences.
3 IN540527B Herbal formulation for the treatment of menopausal syndrome 2020-06-18 Menopausal Syndrome A herbal formulation comprising lyophilized powder of Cynodon dactylon and Foeniculum vulgare for the management of menopausal syndrome.
4 IN458643B A novel pro-apoptotic peptide for selective elimination of malignant cells 2018-01-31 Cancer The invention describes a synthetic pro-apoptotic peptide designed for the targeted elimination of tumor cells, specifically through the activation of the Protease Activated Receptor 1 (PAR1). The peptide sequence is N-PFISED-COOH when independent and PFISED when part of PAR1, which is activated by Vibrio cholerae autotransporter protease (HAP).
5 IN402534B Cp an antimicrobial peptide, a process of preparation, and a method of attenuating microbes thereof 2018-01-03 Gram-Negative bacterial infection This invention relates to a novel antimicrobial peptide designated as CP, with the sequence GQLRRLGRKILPAVKKYG, designed for use in various forms such as injectable solutions, cream, or powder. This peptide specifically targets Gram-negative bacteria, including Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae, while exhibiting negligible haemolytic activity.
6 IN435514B Mapcon-a consensus based myeloid antimicrobial peptide 2017-11-17 Gram-Negative bacterial infection This invention relates to a novel antimicrobial peptide named MAPCON, which comprises the amino acid sequence RGLRRLGRKIKGLKKKYG (SEQ. ID. NO.: 1) and is specifically designed to target Gram-negative bacteria without causing hemolytic effects.
7 IN333035B Alginate chitosan nano formulations of Outer membrane protein A (OmpA) and a method related thereof 2016-05-02 GI Infection A novel formulation for an improved immunogen delivery system utilizing alginate-chitosan nanoparticles encapsulating OMPA protein from Shigella species.
8 IN452521B Nano-engineered biodegradable polymer composite for bone-sift tissue fixation application 2016-04-13 Bone and Tissue Regeneration A biodegradable polymer composite designed for orthopaedic applications, specifically for the treatment of soft tissue injuries and small bone fractures, utilizing a blend of Magnesium Oxide, silk fibroin, and a bioresorbable polymer matrix.
9 IN431100B A peptide to neutralize lipopolysaccharide molecule 2015-02-18 Sepsis A peptide designed to bind and neutralize lipopolysaccharide (LPS), consisting of a seven-residue sequence featuring a central Proline-Tryptophan-Tryptophan-Proline-Tryptophan motif flanked by positively charged amino acids.
10 IN310696B Formulation with recombinant human lung surfactant protein sp-d for sexually transmitted infections including hiv 2010-02-12 HIV A formulation comprising recombinant human surfactant protein D (rhSP-D) targeting HIV, consisting of specific amino acid sequences and a dosage solution.
11 IN396698B A composition for the treatment of liver diseases 2014-09-15 Liver disease A novel composition combining silymarin, fulvic acid, and piperine aimed at improving the bioavailability and bio-efficacy of silymarin for liver disease treatment.
12 IN269659B A composition for selectively eliminating a microorganism or a group of microorganisms from biological sample 2008-12-12 Tuberculosis A composition for selectively eliminating Mycobacterium from biological samples, particularly for isolating Mycobacterium tuberculosis, comprising phage biotics complemented with phage lysin, with a titre range of 1X10^7 pfu/ml to 1X10^11 pfu/ml.
13 IN467810B A process for the chemical synthesis of alpha hydroxy succinamic acid; a herbal antidiabetic compound isolated from e. jambolana 2019-07-26 Diabetes The invention pertains to the field of synthetic organic chemistry, specifically focusing on the efficient preparation of 4-amino-2-hydroxy-4-oxobutanoic acid, which serves as an active pharmaceutical ingredient for managing type 2 diabetes mellitus and its complications.
14 IN391961B A process for the preparation of a fibrinolytic enzyme 2014-01-06 Generalised A novel process for the preparation of a fibrinolytic enzyme derived from Bacillus sphaericus serotype H5a 5b, achieving a yield improvement of approximately 7 times.
15 IN344829B A process for the production of cyclosporin-a 2013-03-12 Autoimmune Diseases A novel process for producing Cyclosporin-A (Cyc-A) using the fungus Tolypocladium sp., strain NRRL No. 18950, involving specific nutrient mediums and treatment steps to enhance yield.
5. Miscellaneous
S. No. Patent No. Title Filing Date Field of Invention Indication Summary
1 IN434798B Fortified instant curd/yoghurt composition for anti-cholesterolosis/toxic effect 2019-05-20 Functional food Food and Nutrition A composition comprising yogurt ingredients to 8g w/w of soy milk and 2 to 10 w % of bitter gourd seed oil, designed for lactose-intolerant consumers.
2 IN342681B Gluten and casein free cookie 2016-06-15 Functional food Food and Nutrition A novel healthy formulation of gluten and casein free cookies specifically designed for autistic children, utilizing a blend of alternative flours and nutrient-rich ingredients.
3 IN513015B Poliovirus receptor (pvr/cd155) knockout cells derived from of (human rhabdomyosarcoma) cell line by CRISPR 2018-09-14 Cell lines Polio This invention provides cell lines comprising said modified gene and method of producing the same using clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (CRISPR-Cas9) system. The said cell line is refractory (non-permissive) to poliovirus and enteroviruses and many other human viruses.
4 IN539301B Plant extract-based composition useful for leishmania promastigotes 2013-04-26 Culture Medium Vector Borne Diseases A novel culture medium for the cultivation of Leishmania promastigotes, utilizing plant extracts from various medicinal plants designed to be serum-free and devoid of animal products.
5 IN536158B A bioactive composite deposited calcium[ca] and a process for preparing the same 2020-07-17 Bone and Tissue Regeneration Osseointegration A bioactive composite comprising Zr, Si, Sr, along with specific nanoparticles impregnated with Quercetin, specifically designed for orthopaedic applications such as osteo-implant.
6 IN561237B A surface active, compatibilized and biodegradable electrospun mat 2022-02-23 Bone and Tissue Regeneration Bone and Tissue Regeneration A surface-active, compatibilized, biodegradable electrospun copolymer of Poly(L-lactide-co-ε-caprolactone) (PLCL) and a polylactic acid (PLA) polymer blend in an optimized ratio with drug loading to enhance integrity and mechanical strength. This enables efficient adsorption of hydroxayapatite and similar biomineralizing molecules, making it highly suitable for biomedical applications such as barrier membranes, dentin-repair materials, and other regenerative device designs.
7 IN421140B A novel fumigation methodology for antibacterial action 2016-05-11 Agrochemicals /Agriculture Engineering Generalised A solution for fumigation utilizing a specially designed fumigation chamber and herbal fumigant mixtures to achieve antibacterial effects against a wide range of pathogenic bacteria.
8 IN462167B A combustible coil composition 2017-08-08 Agrochemicals /Agriculture Engineering Vector Borne Diseases A novel combustible coil composition utilizing castor bean cake as an active ingredient for effective mosquito control.
9 IN543698B Device for developing germfree and gnotobiotic mosquitoes 2019-12-04 Bio-Medical Engineering Vector Borne Diseases A device designed for the rearing and incubation of germfree and gnotobiotic insects, particularly mosquitoes, featuring a cuboid support structure with a non-porous cover, closure device, and a neck provision for a porous element that allows sterilized air to pass through.
10 IN490754B Structure of eco-friendly mosquito larvae trapping device 2020-05-01 Mechanical Engineering Vector Borne Diseases A device designed to capture mosquito eggs and larvae using a breeding tray, conical barriers, and a 'U' shaped collection tube, all enclosed in a transparent casing.
11 IN451267B An improved alcoholic composition and methodology therefor 2016-03-08 Beverages Generalised An innovative alcoholic beverage derived from fermented Kombucha tea and black tea, enriched with antioxidant properties.
12 IN435940B A process for the preparation of an eco-friendly dehairing protease enzyme from bacillus sp. for leather processing 2012-08-27 Microbiology Leather Dehairing A novel process for producing an eco-friendly protease enzyme from Bacillus thuringiensis var. israelensis, aimed at replacing toxic chemicals in leather processing.